Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Assets Average (2016 - 2025)

Traws Pharma (TRAW) has disclosed Assets Average for 13 consecutive years, with $11.5 million as the latest value for Q4 2025.

  • For Q4 2025, Assets Average fell 31.97% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $11.5 million, down 31.97%, while the annual FY2025 figure was $17.8 million, 25.32% down from the prior year.
  • Assets Average hit $11.5 million in Q4 2025 for Traws Pharma, down from $14.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $57.7 million in Q4 2021 and bottomed at $11.5 million in Q4 2025.
  • Average Assets Average over 5 years is $32.0 million, with a median of $30.8 million recorded in 2023.
  • Year-over-year, Assets Average surged 155.5% in 2021 and then crashed 51.97% in 2024.
  • Traws Pharma's Assets Average stood at $57.7 million in 2021, then decreased by 27.99% to $41.6 million in 2022, then crashed by 40.2% to $24.9 million in 2023, then plummeted by 31.82% to $16.9 million in 2024, then tumbled by 31.97% to $11.5 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $11.5 million, $14.0 million, and $17.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.